- Home
- ELPC vs AXSM Comparison
ELPC vs AXSM Comparison
Compare ELPC & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELPC
- AXSM
- Stock Information
- Founded
- ELPC 1954
- AXSM 2012
- Country
- ELPC Brazil
- AXSM United States
- Employees
- ELPC N/A
- AXSM N/A
- Industry
- ELPC Electric Utilities: Central
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- ELPC Utilities
- AXSM Health Care
- Exchange
- ELPC Nasdaq
- AXSM Nasdaq
- Market Cap
- ELPC 4.8B
- AXSM 4.4B
- IPO Year
- ELPC N/A
- AXSM 2015
- Fundamental
- Price
- ELPC $5.74
- AXSM $98.19
- Analyst Decision
- ELPC
- AXSM Strong Buy
- Analyst Count
- ELPC 0
- AXSM 14
- Target Price
- ELPC N/A
- AXSM $124.93
- AVG Volume (30 Days)
- ELPC 27.3K
- AXSM 536.9K
- Earning Date
- ELPC 01-01-0001
- AXSM 11-12-2024
- Dividend Yield
- ELPC N/A
- AXSM N/A
- EPS Growth
- ELPC 43.89
- AXSM N/A
- EPS
- ELPC 0.19
- AXSM N/A
- Revenue
- ELPC $4,076,906,276.00
- AXSM $338,457,000.00
- Revenue This Year
- ELPC N/A
- AXSM $40.67
- Revenue Next Year
- ELPC $8.16
- AXSM $69.27
- P/E Ratio
- ELPC $8.32
- AXSM N/A
- Revenue Growth
- ELPC 4.83
- AXSM 51.47
- 52 Week Low
- ELPC $5.49
- AXSM $60.28
- 52 Week High
- ELPC $8.25
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- ELPC 39.36
- AXSM 61.45
- Support Level
- ELPC $5.49
- AXSM $90.86
- Resistance Level
- ELPC $6.03
- AXSM $105.00
- Average True Range (ATR)
- ELPC 0.12
- AXSM 4.06
- MACD
- ELPC 0.03
- AXSM 0.44
- Stochastic Oscillator
- ELPC 40.83
- AXSM 64.04
About ELPC Companhia Paranaense de Energia (COPEL) (each representing four (4))
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Holding and Services. Majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.